Efficacy and safety of mipomersen sodium (Kynamro)

By Hovingh Kees  

Expert Opinion on Drug Safety, Vol. 12, Iss. 4, 2013-07 ,pp. : 569-579

Informa Healthcare

Access to resources Recommend Favorite

Mipomersen as a potential adjunctive therapy for hypercholesterolemia

By Patel Neeraj   Hegele Robert A  

Expert Opinion on Pharmacotherapy, Vol. 11, Iss. 15, 2010-10 ,pp. : 2569-2572

Informa Healthcare

Access to resources Recommend Favorite

Therapeutic Potential of Mipomersen in the Management of Familial Hypercholesterolaemia

By Gelsinger Carmen   Steinhagen-Thiessen Elisabeth   Kassner Ursula  

Drugs, Vol. 72, Iss. 11, 2012-07 ,pp. : 1445-1455

Adis International

Access to resources Recommend Favorite

Apolipoprotein B Antisense Inhibition -Update on Mipomersen

By  

Current Pharmaceutical Design, Vol. 19, Iss. 17, 2013-05 ,pp. : 3132-3142

Bentham Science Publishers

Access to resources Recommend Favorite

The potential of mipomersen, an ApoB synthesis inhibitor, to reduce necessity for LDL-apheresis in patients with heterozygous familial hypercholesterolemia and coronary artery disease

By Vogt Anja   Parhofer Klaus G  

Expert Opinion on Pharmacotherapy, Vol. 14, Iss. 6, 2013-04 ,pp. : 691-697

Informa Healthcare

Access to resources Recommend Favorite